Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Bioventix Stock Gains Over 6%: Why Healthcare Investors Are Watching This UK Diagnostics Leader

Bioventix Plc recorded a6.67%gain on 24 July 2026 as investors increased exposure to specialist healthcare and biotechnology companies benefiting from expanding global demand for advanced diagnostic solutions.

Ankur Sharma | 24 July 2026

CellXxHealth Stock Climbs on 24 July 2026: Why UK Healthcare Investors Are Watching Closely

CellXxHealth plc gained5.88%on24 July 2026as investors increased exposure to healthcare companies focused on innovative medical technologies and next-generation treatment solutions.

Ankur Sharma | 24 July 2026

Why Did Futura Medical Shares Crash Over 20% Today? Key Reasons Behind the Sharp Sell-Off

LSE:FUM – Futura Medical plcattracted significant attention after its shares fell20.23%during trading on24 July 2026. The sharp decline placed the company among the session's weakest performers and generated strong interest from retail and institutional investors monitoring UK healthcare and biotechnology stocks.

Ankur Sharma | 24 July 2026

LSE:HVO Jumps as Clinical Research Demand Strengthens Healthcare Sector Optimism

hVIVO plc advanced6.42%on24 July 2026as investors increased exposure to specialist healthcare companies benefiting from continued growth across the pharmaceutical and biotechnology industries.

Ankur Sharma | 24 July 2026

Can AstraZeneca Plc Sustain Its Position in Pharmaceuticals?

Companies in the pharmaceuticals space are typically valued using metrics relevant to their business model and sector peers.

Ishan Mudgal | 24 July 2026

Can GSK Plc Sustain Its Position in Pharmaceuticals?

Companies in the pharmaceuticals space are typically valued using metrics relevant to their business model and sector peers.

Ishan Mudgal | 24 July 2026

Scancell Holdings (LSE:SCLP) Slides as Discounted Fundraising, Dilution Concerns and Biotech Volatility Weigh on Investor Sentiment

Scancell Holdings Plc is a late-stage clinical immuno-oncology company developing active cancer immunotherapies designed to stimulate the immune system against difficult-to-treat cancers. The company generates value through clinical development, strategic partnerships and potential future commercialisation rather than recurring product revenues. Despite announcing transformational strategic …

Ankur Sharma | 23 July 2026

Proteome Sciences plc News Today: What the Latest Market Developments Mean for Investors

Proteome Sciences plc (LSE:PRM) attracted significant investor attention after its shares declined7.47%during trading on23 July 2026, placing the company among the largest fallers within the UK healthcare sector.

Ankur Sharma | 23 July 2026

LSE:THAT Drops 7.14%: What's Behind Today's Sell-Off in Thalia Therapeutics PLC?

Thalia Therapeutics PLC (LSE:THAT) came under the spotlight after its shares declined7.14%during trading on23 July 2026, placing the company among the day's largest healthcare sector decliners.

Ankur Sharma | 23 July 2026

Fusion Antibodies plc Shares Under Pressure: Key Reasons Investors Are Watching LSE:FAB Today

Fusion Antibodies plc (LSE:FAB) attracted investor attention after its shares declined6.05%during trading on23 July 2026.

Ankur Sharma | 23 July 2026
Support

Hi! How can we help you today?

Loading…